OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. Multiple strategies can be employed to antibody titer, comprising process parameter optimization, media optimization, and adoption of perfusion processes. Fine-tuning media composition plays a cruc